News & Updates

Initial mobility assessment in VTE risk stratification lacks accuracy
Initial mobility assessment in VTE risk stratification lacks accuracy
27 Aug 2024

Initial clinical mobility assessments during venous thromboembolism (VTE) risk evaluation do not seem to convey patient mobility during their hospital stay, reveals a study.

Initial mobility assessment in VTE risk stratification lacks accuracy
27 Aug 2024
Standardized guidelines missing for treatment of GILCNEC
Standardized guidelines missing for treatment of GILCNEC
23 Aug 2024 byStephen Padilla

Patients with gastrointestinal large cell neuroendocrine carcinoma (GILCNEC) show varying prognosis depending on the site of the primary tumour, suggests a study. Unfortunately, there remains no standardized consensus guidelines to manage GILCNEC.

Standardized guidelines missing for treatment of GILCNEC
23 Aug 2024
Cataract surgery may prevent cognitive decline, dementia in older adults
Cataract surgery may prevent cognitive decline, dementia in older adults
21 Aug 2024

A recent study has observed a possible link between cataract surgery and a reduced risk of cognitive impairment and dementia, indicating cataract-related vision impairment as a potentially modifiable risk factor for cognitive decline.

Cataract surgery may prevent cognitive decline, dementia in older adults
21 Aug 2024
Sildenafil shows promise as treatment for Alzheimer’s disease
Sildenafil shows promise as treatment for Alzheimer’s disease
15 Aug 2024 byStephen Padilla

Sildenafil, a phosphodiesterase type 5 inhibitor, can be a potential treatment for Alzheimer’s disease (AD), as shown in real-world data, AD patient-induced pluripotent stem cells (iPSC)-derived neuron models, and in vivo transgenic mouse model observations, according to a study presented at AAIC 2024.

Sildenafil shows promise as treatment for Alzheimer’s disease
15 Aug 2024